Acadian Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-587
| Closed | -$58K | – | 1929 |
|
|
2024
Q3 | $58K | Buy |
+587
| New | +$58K | ﹤0.01% | 1755 |
|
|
2021
Q1 | – | Sell |
-146,397
| Closed | -$9.08M | – | 2198 |
|
|
2020
Q4 | $9.08M | Hold |
146,397
| – | – | 0.04% | 359 |
|
|
2020
Q3 | $8.71M | Sell |
146,397
-2,429
| -2% | -$144K | 0.04% | 335 |
|
|
2020
Q2 | $10.4M | Hold |
148,826
| – | – | 0.04% | 322 |
|
|
2020
Q1 | $6.75M | Hold |
148,826
| – | – | 0.04% | 331 |
|
|
2019
Q4 | $9.68M | Buy |
148,826
+20,147
| +16% | +$1.31M | 0.04% | 313 |
|
|
2019
Q3 | $7.99M | Buy |
128,679
+2,698
| +2% | +$168K | 0.03% | 381 |
|
|
2019
Q2 | $8.97M | Buy |
125,981
+92,687
| +278% | +$6.6M | 0.04% | 296 |
|
|
2019
Q1 | $2.61M | Buy |
+33,294
| New | +$2.61M | 0.01% | 625 |
|
|
2018
Q4 | – | Sell |
-45
| Closed | -$8K | – | 1775 |
|
|
2018
Q3 | $8K | Sell |
45
-958
| -96% | -$170K | ﹤0.01% | 1572 |
|
|
2018
Q2 | $129K | Sell |
1,003
-7,017
| -87% | -$902K | ﹤0.01% | 1179 |
|
|
2018
Q1 | $826K | Buy |
+8,020
| New | +$826K | ﹤0.01% | 751 |
|
|
2015
Q2 | – | Sell |
-2,058
| Closed | -$99K | – | 1435 |
|
|
2015
Q1 | $99K | Buy |
+2,058
| New | +$99K | ﹤0.01% | 1020 |
|
|
2014
Q4 | – | Sell |
-6,415
| Closed | -$188K | – | 1297 |
|
|
2014
Q3 | $188K | Buy |
+6,415
| New | +$188K | ﹤0.01% | 775 |
|